
AI predicts kidney cancer immunotherapy survival rates
A new machine learning model uses basic blood markers to predict how kidney cancer patients respond to immunotherapy.
Discover the newest research about AI innovations in 👤 Personalized Medicine.

A new machine learning model uses basic blood markers to predict how kidney cancer patients respond to immunotherapy.

A new digital twin model shows that one-third of heart failure patients fail cardiac therapy because surgeons are aiming at the wrong target.

By combining two different genomic signals, researchers proved that cheap, shallow DNA sequencing can catch ovarian cancer with high accuracy.

A new benchmark shows that expensive tabular foundation models offer almost no performance advantage over classic machine learning for predicting patient outcomes.

An AI model that calculates biological age from a simple eye photo could shift systemic disease screening from specialized clinics to the optometrist’s chair.

A new AI system called MedGenesis can compress years of clinical research into hours by autonomously generating hypotheses and analyzing patient data.

A new AI model predicts immunotherapy success across different cancers by translating complex genetic data into clear biological concepts.

A newly validated artificial intelligence model is challenging the expensive, slow-moving monopoly of genomic sequencing in breast cancer care.

A new AI tool bypasses the limits of scarce patient data to identify a two-protein signature that accurately flags a deadly, non-HPV cervical cancer.

A new language model attempts to solve a major diagnostic bias by separating normal hormonal transitions from actual viral damage in women.